Kraton Performance Polymers, Inc. Announces Underwriters’ Exercise of Over-Allotment Option

Kraton Performance Polymers, Inc. (the “Company”) is issuing this press release to clarify its January 7, 2010 press release. In the January 7, 2010 press release, the number of shares of Company common stock sold in the offering after giving effect to the over-allotment option was stated as 30,596,196 shares. The correct number is 11,181,200 shares sold in the offering. 30,596,196 shares is the total number of shares of common stock issued and outstanding after giving effect to the over-allotment option. The complete corrected text follows.
On January 7, 2010, the Company announced that the underwriters have exercised their option to purchase 887,082 additional shares of common stock from the Company at the public offering price less the underwriting discount to cover over-allotments.
After giving effect to the sale of the shares sold pursuant to the over-allotment option, a total of 11,181,200 shares of Company common stock were sold in the offering by the Company at a price to the public of $13.50.
The sale of the over-allotment shares closed on January 7, 2010.
The shares are listed on the New York Stock Exchange and trade under the symbol “KRA.”
Credit Suisse Securities (USA) LLC, BofA Merrill Lynch, Morgan Stanley & Co. Incorporated and Oppenheimer & Co. Inc. are the bookrunning managers of the offering. A copy of the final prospectus related to the offering, when available, may be obtained by contacting: Credit Suisse Securities (USA) LLC, Attn: Credit Suisse Prospectus Department, One Madison Avenue, New York, NY 10010, Phone: 1-800-221-1037; BofA Merrill Lynch, 4 World Financial Center, New York, NY 10080, Attn: Preliminary Prospectus Department or email [email protected]; Morgan Stanley & Co. Incorporated, Attn: Prospectus Department, 180 Varick Street, New York, NY 10014 or [email protected]; or Oppenheimer & Co. Inc. Attn: Syndicate Prospectus Department, 300 Madison Ave., 4th Floor, New York, New York 10017, Phone (212) 667-8563, Fax (212) 667-6141, or [email protected].
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.